ZA974422B - Substituted-amidinobenzene derivative and pharmaceutical compositions thereof. - Google Patents

Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.

Info

Publication number
ZA974422B
ZA974422B ZA9704422A ZA974422A ZA974422B ZA 974422 B ZA974422 B ZA 974422B ZA 9704422 A ZA9704422 A ZA 9704422A ZA 974422 A ZA974422 A ZA 974422A ZA 974422 B ZA974422 B ZA 974422B
Authority
ZA
South Africa
Prior art keywords
substituted
pharmaceutical compositions
amidinobenzene
derivative
amidinobenzene derivative
Prior art date
Application number
ZA9704422A
Other languages
English (en)
Inventor
Yuzo Matsumoto
Seijiro Akamatsu
Masato Ichihara
Tomihisa Kawasaki
Seiji Kaku
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd, Merck Patent Gmbh filed Critical Yamanouchi Pharma Co Ltd
Publication of ZA974422B publication Critical patent/ZA974422B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9704422A 1996-05-30 1997-05-21 Substituted-amidinobenzene derivative and pharmaceutical compositions thereof. ZA974422B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13727396 1996-05-30

Publications (1)

Publication Number Publication Date
ZA974422B true ZA974422B (en) 1997-12-22

Family

ID=15194827

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704422A ZA974422B (en) 1996-05-30 1997-05-21 Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.

Country Status (18)

Country Link
US (1) US6057324A (xx)
EP (1) EP0905129A4 (xx)
KR (1) KR20000016164A (xx)
CN (1) CN1221405A (xx)
AR (1) AR008374A1 (xx)
AU (1) AU720233B2 (xx)
BR (1) BR9709277A (xx)
CA (1) CA2250038A1 (xx)
CZ (1) CZ389698A3 (xx)
HU (1) HUP9903539A3 (xx)
ID (1) ID16991A (xx)
NO (1) NO312097B1 (xx)
PL (1) PL330204A1 (xx)
RU (1) RU2158263C2 (xx)
SK (1) SK162498A3 (xx)
TW (1) TW403745B (xx)
WO (1) WO1997045413A1 (xx)
ZA (1) ZA974422B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006071958A1 (en) * 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
WO2006071875A1 (en) 2004-12-29 2006-07-06 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542363A3 (en) * 1991-11-14 1993-07-14 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
AU4633296A (en) * 1995-02-10 1996-08-27 Yamanouchi Pharmaceutical Co., Ltd. Novel benzamidine derivatives and medicinal composition thereof
JPH0987280A (ja) * 1995-09-28 1997-03-31 Yamanouchi Pharmaceut Co Ltd オキソピペラジン誘導体又はその塩

Also Published As

Publication number Publication date
NO985572L (no) 1999-01-26
RU2158263C2 (ru) 2000-10-27
NO985572D0 (no) 1998-11-27
AU720233B2 (en) 2000-05-25
HUP9903539A2 (hu) 2000-05-28
TW403745B (en) 2000-09-01
AR008374A1 (es) 2000-01-19
WO1997045413A1 (fr) 1997-12-04
EP0905129A1 (en) 1999-03-31
NO312097B1 (no) 2002-03-18
CA2250038A1 (en) 1997-12-04
BR9709277A (pt) 1999-08-10
CN1221405A (zh) 1999-06-30
US6057324A (en) 2000-05-02
HUP9903539A3 (en) 2002-01-28
AU2975997A (en) 1998-01-05
PL330204A1 (en) 1999-04-26
ID16991A (id) 1997-11-27
KR20000016164A (ko) 2000-03-25
EP0905129A4 (en) 2000-03-15
CZ389698A3 (cs) 1999-02-17
SK162498A3 (en) 1999-06-11

Similar Documents

Publication Publication Date Title
HUP0002869A3 (en) Benzothiophenecarboxamide derivatives, pharmaceutical compositions thereof and intermediates
EG24118A (en) Pharmaceutical compositions
ZA9710071B (en) Pharmaceutical composition.
ZA9710927B (en) Pharmaceutical composition.
AU4762797A (en) Pharmaceutical compositions
ZA977104B (en) Pharmaceutical compositions.
GB9610359D0 (en) Pharmaceutical compositions
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
GB9622681D0 (en) Pharmaceutical compositions
ZA972602B (en) Pharmaceutical compositions.
GB9613457D0 (en) Pharmaceutical compositions
NZ329271A (en) 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
AU4326197A (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
GB9623962D0 (en) Pharmaceutical composition
AUPN862596A0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
ZA974422B (en) Substituted-amidinobenzene derivative and pharmaceutical compositions thereof.
HUP9700609A3 (en) 1,25-dihydroxy-12,22,23-trisdehydro-cholecalciferol derivatives, pharmaceutical compositions containing the same and intermediates
ZA976028B (en) Pharmaceutical compositions.
ZA9811315B (en) 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same.
GB9603942D0 (en) Pharmaceutical compositions
GB9606586D0 (en) Pharmaceutical compositions